• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Valeant To Sell Filler And Toxin Assets To Nestle For $1.4 Billion









another indication that the deal is done is today's AGN stock prices ...

all the short term interest is running away

institutionals and hedgies are coming in who will sell to VRX